MA
LLY icon

MAS Advisors’s Eli Lilly LLY Stock Holding History

MAS Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-364
Closed -$284K – 69
2025
Q2 		$284K Buy
364
+3
+0.8% +$2.33K 0.46% 57
2025
Q1 		$298K Hold
361
– – 0.46% 53
2024
Q4 		$279K Hold
361
– – 0.47% 56
2024
Q3 		$320K Sell
361
-15
-4% -$13.5K 0.68% 50
2024
Q2 		$340K Buy
376
+14
+4% +$11.2K 0.81% 46
2024
Q1 		$282K Buy
+362
New +$258K 0.33% 56

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MAS Advisors's LLY Position: Q3 2025 in Review

MAS Advisors sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 364 shares — an estimated $284K sold.

MAS Advisors first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $340K in Q2 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • MAS Advisors reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • MAS Advisors sold 364 Eli Lilly shares in Q3 2025, an estimated $284K.
  • MAS Advisors first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • MAS Advisors's Eli Lilly position peaked at $340K in Q2 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on MAS Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.